Personalised medicine in gynaecological cancers
How to test and define HRD positive population in ovarian cancer
Date
09 Oct 2016Session
Personalised medicine in gynaecological cancersPresenters
Iain McNeishAuthors
I. McNeishAuthor affiliations
- Wolfson Wohl Cancer Research Centre, University of Glasgow Beatson Institute for Cancer Research, G61 1QH - Glasgow/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Andrés Poveda
Session: Personalised medicine in gynaecological cancers
Resources:
Slides
Webcast
Immunotherapy in ovarian cancer
Presenter: Lana Kandalaft
Session: Personalised medicine in gynaecological cancers
Resources:
Slides
Webcast